Business Context and Reporting Period
This Form 8-K is filed by Petra Acquisition, Inc. (not Revelation Biosciences, Inc.) on June 15, 2021. The filing addresses a material accounting error regarding the classification of Private Warrants issued during the company's initial public offering. The error impacts financial statements for the year ended December 31, 2020, and interim reports filed on October 19, 2020.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. Instead, it discloses a qualitative accounting adjustment:
- Warrant Classification: Private Warrants were previously classified as equity but must be reclassified as derivative liabilities.
- Impact: This reclassification affects the balance sheet presentation and potentially the valuation of liabilities, though specific monetary adjustments are not detailed in this text.
Material Changes Versus Prior Period
The primary material change is the non-reliance on previously issued financial statements. The Audit Committee determined that the 2020 Form 10-K and the October 19, 2020 Form 8-K are no longer reliable due to the warrant classification error. This change was triggered by an April 12, 2021, SEC Staff Statement clarifying that certain SPAC warrant terms preclude equity classification.
Guidance, Outlook, and Risks
- Management Action: Petra plans to file an amendment to its 2020 Form 10-K to correct the accounting treatment of the Private Warrants.
- Internal Controls: Management's reports on the effectiveness of internal controls over financial reporting for the period are no longer reliable.
- Risk: The filing highlights the risk of restatement and the potential impact on the company's financial position once the liability classification is applied.
Investor Verification Checklist
- Verify the upcoming amended Form 10-K for the year ended December 31, 2020, to see the quantified impact of reclassifying warrants as liabilities.
- Confirm the specific terms of the Private Warrants that led to the derivative liability classification under the new SEC guidance.
- Review the company's updated liquidity position, as reclassifying equity to liabilities may affect debt covenants or net asset value.
- Check for any subsequent filings regarding the status of the internal control remediation.